Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
Swiss Medical Weekly
|
October 9, 2014
Intensive care without walls - introduction of a Medical Emergency Team system in a Swiss tertiary care centre
Reto Etter, Jukka Takala, Tobias Michael Merz
F1000Prime Reports
|
May 1, 2015
Drug-induced liver injury: the dawn of biomarkers?
Stefan Weiler, Michael Merz, Gerd A Kullak-Ublick
Journal of Surgical Orthopaedic Advances
|
September 5, 2023
No Increased Risk of Aseptic Loosening with Tourniquetless Cemented Total Knee Arthroplasty
Michael Merz, Anil Thomas, Carl Talmo, et al.
Behavioural Brain Research
|
November 27, 2007
D2 receptor density and prepulse inhibition in humans: negative findings from a molecular genetic approach
Christian Montag, Peter Hartmann, Michael Merz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 3, 2015
Octreotide inhibits the bilirubin carriers organic anion transporting polypeptides 1B1 and 1B3 and the multidrug resistance-associated protein 2
Michele Visentin, Bruno Stieger, Michael Merz, et al.
Journal of Agricultural and Food Chemistry
|
December 28, 2020
Impact of Peptidase Activities on Plant Protein Hydrolysates Regarding Bitter and Umami Taste
Kora Kassandra Großmann, Michael Merz, Daniel Appel, et al.
Drug Safety
|
May 17, 2017
Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM
Erik Scalfaro, Henk Johan Streefkerk, Michael Merz, et al.
Plos One
|
September 29, 2022
A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT)
Hans L Tillmann, Ayako Suzuki, Michael Merz, et al.
Acta Crystallographica. Section B, Structural Science
|
September 20, 2006
Modulated corrugations in the crystal structure of the superconductor CaAlSi
Karine M Sparta, Ralf Müller, Michael Merz, et al.
Drug Safety
|
October 30, 2014
Liver safety assessment in special populations (hepatitis B, C, and oncology trials)
Gerd A Kullak-Ublick, Michael Merz, Louis Griffel, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
Swiss Medical Weekly
|
October 9, 2014
Intensive care without walls - introduction of a Medical Emergency Team system in a Swiss tertiary care centre
Reto Etter, Jukka Takala, Tobias Michael Merz
F1000Prime Reports
|
May 1, 2015
Drug-induced liver injury: the dawn of biomarkers?
Stefan Weiler, Michael Merz, Gerd A Kullak-Ublick
Journal of Surgical Orthopaedic Advances
|
September 5, 2023
No Increased Risk of Aseptic Loosening with Tourniquetless Cemented Total Knee Arthroplasty
Michael Merz, Anil Thomas, Carl Talmo, et al.
Behavioural Brain Research
|
November 27, 2007
D2 receptor density and prepulse inhibition in humans: negative findings from a molecular genetic approach
Christian Montag, Peter Hartmann, Michael Merz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 3, 2015
Octreotide inhibits the bilirubin carriers organic anion transporting polypeptides 1B1 and 1B3 and the multidrug resistance-associated protein 2
Michele Visentin, Bruno Stieger, Michael Merz, et al.
Journal of Agricultural and Food Chemistry
|
December 28, 2020
Impact of Peptidase Activities on Plant Protein Hydrolysates Regarding Bitter and Umami Taste
Kora Kassandra Großmann, Michael Merz, Daniel Appel, et al.
Drug Safety
|
May 17, 2017
Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM
Erik Scalfaro, Henk Johan Streefkerk, Michael Merz, et al.
Plos One
|
September 29, 2022
A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT)
Hans L Tillmann, Ayako Suzuki, Michael Merz, et al.
Acta Crystallographica. Section B, Structural Science
|
September 20, 2006
Modulated corrugations in the crystal structure of the superconductor CaAlSi
Karine M Sparta, Ralf Müller, Michael Merz, et al.
Drug Safety
|
October 30, 2014
Liver safety assessment in special populations (hepatitis B, C, and oncology trials)
Gerd A Kullak-Ublick, Michael Merz, Louis Griffel, et al.
Page
of 8